New study suggests that a single dose of 5 mg/kg of FDA-approved CBD medication, administered with food, can achieve detectable CBD concentrations in feline plasma. Further research is needed to determine optimal dosing regimens and evaluate multiple-dose pharmacokinetics. However, these findings provide a promising starting point for future therapeutic trials and potential treatment options for feline epilepsy.